Audubon’s Globus Medical has secured a major courtroom win, writes John George for the Philadelphia Business Journal.
A federal jury awarded the Montco medical device maker $9.5 million in a patent dispute.
The 2021 case alleged that Illinois-based Life Spine’s Prolift line of implants infringed on several Globus patents. The contested technology involves expandable spinal fusion implants designed to improve outcomes for patients undergoing complex back surgeries.
On August 15, a Delaware jury ruled in favor of Globus, awarding $6 million in lost profits and $3.5 million in royalties. CEO Keith Pfeil said the verdict “affirms the strength of our intellectual property” and reflects the company’s role as a leader in musculoskeletal innovation.
The company isn’t stopping there. Globus Medical has additional litigation pending against California’s Alphatec Inc. over similar implant and retractor technology. Executive Vice President and General Counsel Kelly Huller emphasized Globus’ commitment to enforcing its patents against competitors who attempt to use its innovations without authorization.
Founded in 2003, Globus has become one of Montgomery County’s life sciences anchors, employing more than 5,300 people worldwide. Beyond spinal implants, its portfolio includes robotics and navigation systems. In the first half of 2025, Globus reported $1.34 billion in sales, a 9% increase year-over-year.
To learn more about Globus Medical’s ruling, visit the Philadelphia Business Journal.
